T1	Participants 115 233	children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemia
T2	Participants 406 463	hematopoietic stem-cell transplantation (HSCT) recipients
T3	Participants 778 790	178 patients
